{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:58:09Z","timestamp":1792634289755,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41569-024-01071-5","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:02:13Z","timestamp":1726491733000},"page":"165-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Differential roles of eosinophils in cardiovascular disease"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-0469","authenticated-orcid":false,"given":"Junyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-502X","authenticated-orcid":false,"given":"Peter","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5284-2213","authenticated-orcid":false,"given":"Jinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"1071_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","volume":"10","author":"P Khoury","year":"2014","unstructured":"Khoury, P., Grayson, P. C. & Klion, A. D. Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat. Rev. Rheumatol. 10, 474\u2013483 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1071_CR2","doi-asserted-by":"publisher","unstructured":"Wen, T. & Rothenberg, M. E. The regulatory function of eosinophils. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0020-2015 (2016).","DOI":"10.1128\/microbiolspec.MCHD-0020-2015"},{"key":"1071_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2183\/pjab.87.463","volume":"87","author":"K Takatsu","year":"2011","unstructured":"Takatsu, K. Interleukin-5 and IL-5 receptor in health and diseases. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 87, 463\u2013485 (2011).","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"1071_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.coi.2008.04.001","volume":"20","author":"K Takatsu","year":"2008","unstructured":"Takatsu, K. & Nakajima, H. IL-5 and eosinophilia. Curr. Opin. Immunol. 20, 288\u2013294 (2008).","journal-title":"Curr. Opin. Immunol."},{"key":"1071_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","volume":"21","author":"T Kouro","year":"2009","unstructured":"Kouro, T. & Takatsu, K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int. Immunol. 21, 1303\u20131309 (2009).","journal-title":"Int. Immunol."},{"key":"1071_CR6","doi-asserted-by":"publisher","first-page":"9095275","DOI":"10.1155\/2018\/9095275","volume":"2018","author":"GA Ramirez","year":"2018","unstructured":"Ramirez, G. A. et al. Eosinophils from physiology to disease: a comprehensive review. Biomed. Res. Int. 2018, 9095275 (2018).","journal-title":"Biomed. Res. Int."},{"key":"1071_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.1201475","volume":"332","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243\u2013247 (2011).","journal-title":"Science"},{"key":"1071_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20121964","volume":"210","author":"AB Molofsky","year":"2013","unstructured":"Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535\u2013549 (2013).","journal-title":"J. Exp. Med."},{"key":"1071_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28371-4","volume":"8","author":"EH Lee","year":"2018","unstructured":"Lee, E. H. et al. Eosinophils support adipocyte maturation and promote glucose tolerance in obesity. Sci. Rep. 8, 9894 (2018).","journal-title":"Sci. Rep."},{"key":"1071_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","volume":"5","author":"F Davoine","year":"2014","unstructured":"Davoine, F. & Lacy, P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front. Immunol. 5, 570 (2014).","journal-title":"Front. Immunol."},{"key":"1071_CR11","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.4049\/jimmunol.1301176","volume":"191","author":"E Hams","year":"2013","unstructured":"Hams, E., Locksley, R. M., McKenzie, A. N. & Fallon, P. G. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 191, 5349\u20135353 (2013).","journal-title":"J. Immunol."},{"key":"1071_CR12","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI85664","volume":"126","author":"C Mesnil","year":"2016","unstructured":"Mesnil, C. et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J. Clin. Invest. 126, 3279\u20133295 (2016).","journal-title":"J. Clin. Invest."},{"key":"1071_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","volume":"323","author":"J Bousquet","year":"1990","unstructured":"Bousquet, J. et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323, 1033\u20131039 (1990).","journal-title":"N. Engl. J. Med."},{"key":"1071_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fmed.2017.00093","volume":"4","author":"CN McBrien","year":"2017","unstructured":"McBrien, C. N. & Menzies-Gow, A. The biology of eosinophils and their role in asthma. Front. Med. 4, 93 (2017).","journal-title":"Front. Med."},{"key":"1071_CR15","doi-asserted-by":"publisher","first-page":"1901874","DOI":"10.1183\/13993003.01874-2019","volume":"55","author":"S Hartl","year":"2020","unstructured":"Hartl, S. et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur. Respir. J. 55, 1901874 (2020).","journal-title":"Eur. Respir. J."},{"key":"1071_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/ATVBAHA.115.305911","volume":"36","author":"CL Liu","year":"2016","unstructured":"Liu, C. L. et al. Allergic lung inflammation aggravates angiotensin II-induced abdominal aortic aneurysms in mice. Arterioscler. Thromb. Vasc. Biol. 36, 69\u201377 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1071_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2016.01.008","volume":"171","author":"CL Liu","year":"2016","unstructured":"Liu, C. L. et al. Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice. Transl. Res. 171, 1\u201316 (2016).","journal-title":"Transl. Res."},{"key":"1071_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.115.306497","volume":"36","author":"CL Liu","year":"2016","unstructured":"Liu, C. L. et al. Asthma associates with human abdominal aortic aneurysm and rupture. Arterioscler. Thromb. Vasc. Biol. 36, 570\u2013578 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1071_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s44161-022-00067-z","volume":"1","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Allergic asthma is a risk factor for human cardiovascular diseases. Nat. Cardiovasc. Res. 1, 417\u2013430 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1071_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIRCRESAHA.120.318182","volume":"128","author":"CL Liu","year":"2021","unstructured":"Liu, C. L. et al. Eosinophils protect mice from angiotensin-II perfusion-induced abdominal aortic aneurysm. Circ. Res. 128, 188\u2013202 (2021).","journal-title":"Circ. Res."},{"key":"1071_CR21","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/eurheartj\/ehad262","volume":"44","author":"Z Meng","year":"2023","unstructured":"Meng, Z. et al. Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis. Eur. Heart J. 44, 2763\u20132783 (2023).","journal-title":"Eur. Heart J."},{"key":"1071_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/ATVBAHA.118.310945","volume":"38","author":"C Welsh","year":"2018","unstructured":"Welsh, C. et al. Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arterioscler. Thromb. Vasc. Biol. 38, 1415\u20131423 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1071_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yjmcc.2019.11.156","volume":"138","author":"HE Groot","year":"2020","unstructured":"Groot, H. E., van Blokland, I. V., Lipsic, E., Karper, J. C. & van der Harst, P. Leukocyte profiles across the cardiovascular disease continuum: a population-based cohort study. J. Mol. Cell. Cardiol. 138, 158\u2013164 (2020).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1071_CR24","first-page":"74","volume":"40","author":"AE Nadimi","year":"2008","unstructured":"Nadimi, A. E., Ahmadi, J. & Mehrabian, M. Peripheral eosinophil count and allergy in patients with coronary artery disease. Acta Med. Indones. 40, 74\u201377 (2008).","journal-title":"Acta Med. Indones."},{"key":"1071_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jacig.2022.09.001","volume":"1","author":"T Pongdee","year":"2022","unstructured":"Pongdee, T. et al. Rethinking blood eosinophil counts: epidemiology, associated chronic diseases, and increased risks of cardiovascular disease. J. Allergy Clin. Immunol. Glob. 1, 233\u2013240 (2022).","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"1071_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/eurheartj\/ehp120","volume":"30","author":"G Niccoli","year":"2009","unstructured":"Niccoli, G. et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur. Heart J. 30, 1340\u20131347 (2009).","journal-title":"Eur. Heart J."},{"key":"1071_CR27","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaip.2020.12.031","volume":"9","author":"JB Quinta","year":"2021","unstructured":"Quinta, J. B. et al. Cardiovascular adverse effects of anti-IL-5\/IL-5Ralpha therapies: a real-world study. J. Allergy Clin. Immunol. Pract. 9, 1411\u20131413 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1071_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11239-014-1120-3","volume":"39","author":"M Verdoia","year":"2015","unstructured":"Verdoia, M. et al. Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. J. Thromb. Thrombolysis 39, 459\u2013466 (2015).","journal-title":"J. Thromb. Thrombolysis"},{"key":"1071_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000477","volume":"3","author":"AD Shah","year":"2016","unstructured":"Shah, A. D., Denaxas, S., Nicholas, O., Hingorani, A. D. & Hemingway, H. Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study. Open Heart 3, e000477 (2016).","journal-title":"Open Heart"},{"key":"1071_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2019.05.027","volume":"286","author":"S Gao","year":"2019","unstructured":"Gao, S. et al. Eosinophils count in peripheral circulation is associated with coronary artery disease. Atherosclerosis 286, 128\u2013134 (2019).","journal-title":"Atherosclerosis"},{"key":"1071_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cvr\/cvac144","volume":"119","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells. Cardiovasc. Res. 119, 1046\u20131061 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1071_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206958","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Group 2 innate lymphoid cells protect mice from abdominal aortic aneurysm formation via IL5 and eosinophils. Adv. Sci. 10, e2206958 (2023).","journal-title":"Adv. Sci."},{"key":"1071_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/cvr\/cvac060","volume":"119","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Eosinophils protect pressure overload- and beta-adrenoreceptor agonist-induced cardiac hypertrophy. Cardiovasc. Res. 119, 195\u2013212 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1071_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19297-5","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Eosinophils improve cardiac function after myocardial infarction. Nat. Commun. 11, 6396 (2020).","journal-title":"Nat. Commun."},{"key":"1071_CR35","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/cvr\/cvab237","volume":"118","author":"JY Xu","year":"2022","unstructured":"Xu, J. Y. et al. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovasc. Res. 118, 2165\u20132178 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1071_CR36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jacc.2021.07.018","volume":"78","author":"X Yu","year":"2021","unstructured":"Yu, X. et al. Innate lymphoid cells promote recovery of ventricular function after myocardial infarction. J. Am. Coll. Cardiol. 78, 1127\u20131142 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1071_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacbts.2019.07.002","volume":"4","author":"A Knutsson","year":"2019","unstructured":"Knutsson, A. et al. Associations of interleukin-5 with plaque development and cardiovascular events. JACC Basic Transl. Sci. 4, 891\u2013902 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"1071_CR38","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.2147\/RMHP.S270845","volume":"13","author":"L Gu","year":"2020","unstructured":"Gu, L. et al. The relationship between interleukin-4 levels and cardiovascular events in patients with chronic kidney disease. Risk Manag. Healthc. Policy 13, 2371\u20132377 (2020).","journal-title":"Risk Manag. Healthc. Policy"},{"key":"1071_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2014.12.046","volume":"239","author":"A Silveira","year":"2015","unstructured":"Silveira, A. et al. Plasma IL-5 concentration and subclinical carotid atherosclerosis. Atherosclerosis 239, 125\u2013130 (2015).","journal-title":"Atherosclerosis"},{"key":"1071_CR40","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1046\/j.1365-2222.1999.00542.x","volume":"29","author":"P Venge","year":"1999","unstructured":"Venge, P. et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin. Exp. Allergy 29, 1172\u20131186 (1999).","journal-title":"Clin. Exp. Allergy"},{"key":"1071_CR41","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.4049\/jimmunol.142.12.4428","volume":"142","author":"RI Lehrer","year":"1989","unstructured":"Lehrer, R. I. et al. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol. 142, 4428\u20134434 (1989).","journal-title":"J. Immunol."},{"key":"1071_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000237204","volume":"108","author":"J Chihara","year":"1995","unstructured":"Chihara, J. et al. Possible release of eosinophil granule proteins in response to signaling from intercellular adhesion molecule-1 and its ligands. Int. Arch. Allergy Immunol. 108, 52\u201354 (1995).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"1071_CR43","first-page":"352","volume":"59","author":"J Hernnas","year":"1992","unstructured":"Hernnas, J. et al. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur. J. Cell Biol. 59, 352\u2013363 (1992).","journal-title":"Eur. J. Cell Biol."},{"key":"1071_CR44","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/cvr\/cvad130","volume":"119","author":"JR Pickett","year":"2023","unstructured":"Pickett, J. R., Wu, Y., Zacchi, L. F. & Ta, H. T. Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1-directed novel therapeutics. Cardiovasc. Res. 119, 2278\u20132293 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1071_CR45","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.121.055732","volume":"144","author":"J Barallobre-Barreiro","year":"2021","unstructured":"Barallobre-Barreiro, J. et al. Extracellular matrix in heart failure: role of ADAMTS5 in proteoglycan remodeling. Circulation 144, 2021\u20132034 (2021).","journal-title":"Circulation"},{"key":"1071_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"TY Halim","year":"2014","unstructured":"Halim, T. Y. et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425\u2013435 (2014).","journal-title":"Immunity"},{"key":"1071_CR47","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.4049\/jimmunol.1201212","volume":"190","author":"S Kamijo","year":"2013","unstructured":"Kamijo, S. et al. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J. Immunol. 190, 4489\u20134499 (2013).","journal-title":"J. Immunol."},{"key":"1071_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1189\/jlb.5BT0814-374R","volume":"97","author":"TA Doherty","year":"2015","unstructured":"Doherty, T. A. At the bench: understanding group 2 innate lymphoid cells in disease. J. Leukoc. Biol. 97, 455\u2013467 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"1071_CR49","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","volume":"10","author":"C Pelaia","year":"2019","unstructured":"Pelaia, C. et al. Interleukin-5 in the pathophysiology of severe asthma. Front. Physiol. 10, 1514 (2019).","journal-title":"Front. Physiol."},{"key":"1071_CR50","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/STROKEAHA.116.016436","volume":"48","author":"T Kitano","year":"2017","unstructured":"Kitano, T. et al. Association between absolute eosinophil count and complex aortic arch plaque in patients with acute ischemic stroke. Stroke 48, 1074\u20131076 (2017).","journal-title":"Stroke"},{"key":"1071_CR51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ame2.12277","volume":"5","author":"WJ Xu","year":"2022","unstructured":"Xu, W. J. et al. Arterial and venous thromboembolism risk associated with blood eosinophils: a systematic review and meta-analysis. Anim. Model Exp. Med. 5, 470\u2013481 (2022).","journal-title":"Anim. Model Exp. Med."},{"key":"1071_CR52","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/01.TP.0000076467.83192.42","volume":"76","author":"BM Spriewald","year":"2003","unstructured":"Spriewald, B. M., Ensminger, S. M., Billing, J. S., Morris, P. J. & Wood, K. J. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Transplantation 76, 1105\u20131111 (2003).","journal-title":"Transplantation"},{"key":"1071_CR53","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx, C. et al. Eosinophil\u2013platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood 134, 1859\u20131872 (2019).","journal-title":"Blood"},{"key":"1071_CR54","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"1071_CR55","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/CIRCRESAHA.120.315931","volume":"126","author":"Y Doring","year":"2020","unstructured":"Doring, Y., Libby, P. & Soehnlein, O. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ. Res. 126, 1228\u20131241 (2020).","journal-title":"Circ. Res."},{"key":"1071_CR56","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.123.321750","volume":"132","author":"M Thakur","year":"2023","unstructured":"Thakur, M. et al. NETs-induced thrombosis impacts on cardiovascular and chronic kidney disease. Circ. Res. 132, 933\u2013949 (2023).","journal-title":"Circ. Res."},{"key":"1071_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156453","volume":"132","author":"DF Riascos-Bernal","year":"2022","unstructured":"Riascos-Bernal, D. F. & Sibinga, N. E. Neutrophil extracellular traps in cardiac hypertrophy: a KLF2 perspective. J. Clin. Invest. 132, e156453 (2022).","journal-title":"J. Clin. Invest."},{"key":"1071_CR58","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm.1855","volume":"14","author":"S Yousefi","year":"2008","unstructured":"Yousefi, S. et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14, 949\u2013953 (2008).","journal-title":"Nat. Med."},{"key":"1071_CR59","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1365-2141.1995.tb05211.x","volume":"90","author":"HY Mukai","year":"1995","unstructured":"Mukai, H. Y., Ninomiya, H., Ohtani, K., Nagasawa, T. & Abe, T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br. J. Haematol. 90, 892\u2013899 (1995).","journal-title":"Br. J. Haematol."},{"key":"1071_CR60","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1172\/JCI116382","volume":"91","author":"A Slungaard","year":"1993","unstructured":"Slungaard, A., Vercellotti, G. M., Tran, T., Gleich, G. J. & Key, N. S. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J. Clin. Invest. 91, 1721\u20131730 (1993).","journal-title":"J. Clin. Invest."},{"key":"1071_CR61","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3389\/fimmu.2018.02763","volume":"9","author":"M Mukherjee","year":"2018","unstructured":"Mukherjee, M., Lacy, P. & Ueki, S. Eosinophil extracellular traps and inflammatory pathologies \u2014 untangling the web! Front. Immunol. 9, 2763 (2018).","journal-title":"Front. Immunol."},{"key":"1071_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0634-5","volume":"16","author":"S Ueki","year":"2016","unstructured":"Ueki, S. et al. Eosinophil ETosis and DNA traps: a new look at eosinophilic inflammation. Curr. Allergy Asthma Rep. 16, 54 (2016).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"1071_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/all.13997","volume":"75","author":"Y Choi","year":"2020","unstructured":"Choi, Y. et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy 75, 95\u2013103 (2020).","journal-title":"Allergy"},{"key":"1071_CR64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1600-0609.1972.tb00932.x","volume":"9","author":"I Olsson","year":"1972","unstructured":"Olsson, I. & Venge, P. Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand. J. Haematol. 9, 204\u2013214 (1972).","journal-title":"Scand. J. Haematol."},{"key":"1071_CR65","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.137.6.1459","volume":"137","author":"GJ Gleich","year":"1973","unstructured":"Gleich, G. J., Loegering, D. A. & Maldonado, J. E. Identification of a major basic protein in guinea pig eosinophil granules. J. Exp. Med. 137, 1459\u20131471 (1973).","journal-title":"J. Exp. Med."},{"key":"1071_CR66","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0140-6736(77)90303-8","volume":"2","author":"P Venge","year":"1977","unstructured":"Venge, P., Zetterstrom, O., Dahl, R., Roxin, L. E. & Olsson, I. Low levels of eosinophil cationic proteins in patients with asthma. Lancet 2, 373\u2013375 (1977).","journal-title":"Lancet"},{"key":"1071_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.1979.tb03707.x","volume":"42","author":"R Hallgren","year":"1979","unstructured":"Hallgren, R., Venge, P., Cullhed, I. & Olsson, I. Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration. Br. J. Haematol. 42, 147\u2013154 (1979).","journal-title":"Br. J. Haematol."},{"key":"1071_CR68","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1148\/radiology.137.3.7444045","volume":"137","author":"JR Margolis","year":"1980","unstructured":"Margolis, J. R. et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 137, 609\u2013616 (1980).","journal-title":"Radiology"},{"key":"1071_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0735-1097(97)00147-2","volume":"30","author":"D Baumgart","year":"1997","unstructured":"Baumgart, D. et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J. Am. Coll. Cardiol. 30, 57\u201364 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1071_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0735-1097(96)00479-2","volume":"29","author":"GS Mintz","year":"1997","unstructured":"Mintz, G. S. et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J. Am. Coll. Cardiol. 29, 268\u2013274 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1071_CR71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/hr.2011.191","volume":"35","author":"M Tanaka","year":"2012","unstructured":"Tanaka, M. et al. Eosinophil count is positively correlated with coronary artery calcification. Hypertens. Res. 35, 325\u2013328 (2012).","journal-title":"Hypertens. Res."},{"key":"1071_CR72","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10654-013-9842-7","volume":"28","author":"L Hou","year":"2013","unstructured":"Hou, L. et al. White blood cell count in young adulthood and coronary artery calcification in early middle age: Coronary Artery Risk Development in Young Adults (CARDIA) study. Eur. J. Epidemiol. 28, 735\u2013742 (2013).","journal-title":"Eur. J. Epidemiol."},{"key":"1071_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-1082-6","volume":"16","author":"AC Diederichsen","year":"2015","unstructured":"Diederichsen, A. C. et al. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial. Trials 16, 554 (2015).","journal-title":"Trials"},{"key":"1071_CR74","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jacbts.2020.05.005","volume":"5","author":"IS Toor","year":"2020","unstructured":"Toor, I. S. et al. Eosinophil deficiency promotes aberrant repair and adverse remodeling following acute myocardial infarction. JACC Basic Transl. Sci. 5, 665\u2013681 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"1071_CR75","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2017.05.011","volume":"263","author":"M Qin","year":"2017","unstructured":"Qin, M. et al. Oxidized LDL activated eosinophil polarize macrophage phenotype from M2 to M1 through activation of CD36 scavenger receptor. Atherosclerosis 263, 82\u201391 (2017).","journal-title":"Atherosclerosis"},{"key":"1071_CR76","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1194\/jlr.RA119000312","volume":"61","author":"N Sawada","year":"2020","unstructured":"Sawada, N. et al. Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL. J. Lipid Res. 61, 816\u2013829 (2020).","journal-title":"J. Lipid Res."},{"key":"1071_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1046\/j.1365-2796.2003.01128.x","volume":"253","author":"G Nordin Fredrikson","year":"2003","unstructured":"Nordin Fredrikson, G., Hedblad, B., Berglund, G. & Nilsson, J. Plasma oxidized LDL: a predictor for acute myocardial infarction? J. Intern. Med. 253, 425\u2013429 (2003).","journal-title":"J. Intern. Med."},{"key":"1071_CR78","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fimmu.2020.00802","volume":"11","author":"Y Deng","year":"2020","unstructured":"Deng, Y. et al. Unique phenotypes of heart resident type 2 innate lymphoid cells. Front. Immunol. 11, 802 (2020).","journal-title":"Front. Immunol."},{"key":"1071_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/08820139.2022.2158856","volume":"52","author":"H Yu","year":"2023","unstructured":"Yu, H., Wei, Y., Dong, Y. & Chen, P. Regulation of notch signaling pathway to innate lymphoid cells in patients with acute myocardial infarction. Immunol. Invest. 52, 241\u2013255 (2023).","journal-title":"Immunol. Invest."},{"key":"1071_CR80","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2010.02.038","volume":"211","author":"G Niccoli","year":"2010","unstructured":"Niccoli, G. et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis 211, 606\u2013611 (2010).","journal-title":"Atherosclerosis"},{"key":"1071_CR81","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002554","volume":"8","author":"G Niccoli","year":"2015","unstructured":"Niccoli, G. et al. Allergic inflammation is associated with coronary instability and a worse clinical outcome after acute myocardial infarction. Circ. Cardiovasc. Interv. 8, e002554 (2015).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1071_CR82","doi-asserted-by":"publisher","first-page":"4980251","DOI":"10.1155\/2016\/4980251","volume":"2016","author":"GL Xia","year":"2016","unstructured":"Xia, G. L., Wang, Y. K. & Huang, Z. Q. The correlation of serum myeloid-related protein-8\/14 and eosinophil cationic protein in patients with coronary artery disease. Biomed. Res. Int. 2016, 4980251 (2016).","journal-title":"Biomed. Res. Int."},{"key":"1071_CR83","first-page":"146","volume":"11","author":"A Guner","year":"2020","unstructured":"Guner, A. et al. Eosinophil percentage as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Interv. Med. Appl. Sci. 11, 146\u2013153 (2020).","journal-title":"Interv. Med. Appl. Sci."},{"key":"1071_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/MCA.0000000000000186","volume":"26","author":"P Jiang","year":"2015","unstructured":"Jiang, P., Wang, D. Z., Ren, Y. L., Cai, J. P. & Chen, B. X. Significance of eosinophil accumulation in the thrombus and decrease in peripheral blood in patients with acute coronary syndrome. Coron. Artery Dis. 26, 101\u2013106 (2015).","journal-title":"Coron. Artery Dis."},{"key":"1071_CR85","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1080\/13685538.2019.1643310","volume":"23","author":"I Sincer","year":"2020","unstructured":"Sincer, I., Gunes, Y., Mansiroglu, A. K. & Aktas, G. Differential value of eosinophil count in acute coronary syndrome among elderly patients. Aging Male 23, 958\u2013961 (2020).","journal-title":"Aging Male"},{"key":"1071_CR86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/SHK.0000000000001876","volume":"57","author":"BR Sasmita","year":"2022","unstructured":"Sasmita, B. R. et al. Leukocyte and its subtypes as predictors of short-term outcome in cardiogenic shock complicating acute myocardial infarction: a cohort study. Shock 57, 351\u2013359 (2022).","journal-title":"Shock"},{"key":"1071_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23367","volume":"34","author":"L Ye","year":"2020","unstructured":"Ye, L. et al. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. J. Clin. Lab. Anal. 34, e23367 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"1071_CR88","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/j.amjmed.2019.05.021","volume":"132","author":"M Alkhalil","year":"2019","unstructured":"Alkhalil, M. et al. Eosinopenia as an adverse marker of clinical outcomes in patients presenting with acute myocardial infarction. Am. J. Med. 132, e827\u2013e834 (2019).","journal-title":"Am. J. Med."},{"key":"1071_CR89","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1093\/eurheartj\/ehq299","volume":"31","author":"G Niccoli","year":"2010","unstructured":"Niccoli, G., Kharbanda, R. K., Crea, F. & Banning, A. P. No-reflow: again prevention is better than treatment. Eur. Heart J. 31, 2449\u20132455 (2010).","journal-title":"Eur. Heart J."},{"key":"1071_CR90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","volume":"10","author":"SH Rezkalla","year":"2017","unstructured":"Rezkalla, S. H., Stankowski, R. V., Hanna, J. & Kloner, R. A. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc. Interv. 10, 215\u2013223 (2017).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1071_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22988-2","volume":"12","author":"DG Mo","year":"2022","unstructured":"Mo, D. G., Wang, C. S., Liu, J. H. & Li, T. The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study. Sci. Rep. 12, 17862 (2022).","journal-title":"Sci. Rep."},{"key":"1071_CR92","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.thromres.2012.05.033","volume":"130","author":"IS Toor","year":"2012","unstructured":"Toor, I. S., Jaumdally, R., Lip, G. Y., Millane, T. & Varma, C. Eosinophil count predicts mortality following percutaneous coronary intervention. Thromb. Res. 130, 607\u2013611 (2012).","journal-title":"Thromb. Res."},{"key":"1071_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206344","volume":"13","author":"C Rios-Navarro","year":"2018","unstructured":"Rios-Navarro, C. et al. Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion. PLoS ONE 13, e0206344 (2018).","journal-title":"PLoS ONE"},{"key":"1071_CR94","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio, A. L. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 34, 2636\u20132648 (2013).","journal-title":"Eur. Heart J."},{"key":"1071_CR95","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/hrt.39.3.233","volume":"39","author":"CM Oakley","year":"1977","unstructured":"Oakley, C. M. & Olsen, G. J. Eosinophilia and heart disease. Br. Heart J. 39, 233\u2013237 (1977).","journal-title":"Br. Heart J."},{"key":"1071_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111862","volume":"9","author":"M Cugno","year":"2014","unstructured":"Cugno, M., Marzano, A. V., Lorini, M., Carbonelli, V. & Tedeschi, A. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS ONE 9, e111862 (2014).","journal-title":"PLoS ONE"},{"key":"1071_CR97","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.acvd.2015.01.006","volume":"108","author":"PE Seguela","year":"2015","unstructured":"Seguela, P. E. et al. Eosinophilic cardiac disease: molecular, clinical and imaging aspects. Arch. Cardiovasc. Dis. 108, 258\u2013268 (2015).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"1071_CR98","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.iac.2015.04.002","volume":"35","author":"P Akuthota","year":"2015","unstructured":"Akuthota, P. & Weller, P. F. Spectrum of eosinophilic end-organ manifestations. Immunol. Allergy Clin. North. Am. 35, 403\u2013411 (2015).","journal-title":"Immunol. Allergy Clin. North. Am."},{"key":"1071_CR99","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/eji.201646557","volume":"46","author":"NL Diny","year":"2016","unstructured":"Diny, N. L. et al. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur. J. Immunol. 46, 2749\u20132760 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1071_CR100","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","volume":"70","author":"M Brambatti","year":"2017","unstructured":"Brambatti, M. et al. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J. Am. Coll. Cardiol. 70, 2363\u20132375 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1071_CR101","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.humpath.2004.05.008","volume":"35","author":"D Corradi","year":"2004","unstructured":"Corradi, D. et al. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum. Pathol. 35, 1160\u20131163 (2004).","journal-title":"Hum. Pathol."},{"key":"1071_CR102","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.humpath.2005.03.001","volume":"36","author":"A Janin","year":"2005","unstructured":"Janin, A. Eosinophilic myocarditis and fibrosis. Hum. Pathol. 36, 592\u2013593 (2005).","journal-title":"Hum. Pathol."},{"key":"1071_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000068371","volume":"130","author":"M Hirasawa","year":"2003","unstructured":"Hirasawa, M., Deguchi, H., Ukimura, A. & Kitaura, Y. Immunologic interaction between infiltrating eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis. Int. Arch. Allergy Immunol. 130, 73\u201381 (2003).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"1071_CR104","doi-asserted-by":"publisher","first-page":"H405","DOI":"10.1152\/ajpheart.00133.2019","volume":"317","author":"DR Prows","year":"2019","unstructured":"Prows, D. R., Klingler, A., Gibbons, W. J. Jr, Homan, S. M. & Zimmermann, N. Characterization of a mouse model of hypereosinophilia-associated heart disease. Am. J. Physiol. Heart Circ. Physiol. 317, H405\u2013H414 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1071_CR105","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","volume":"27","author":"PU Ogbogu","year":"2007","unstructured":"Ogbogu, P. U., Rosing, D. R. & Horne, M. K. III Cardiovascular manifestations of hypereosinophilic syndromes. Immunol. Allergy Clin. North. Am. 27, 457\u2013475 (2007).","journal-title":"Immunol. Allergy Clin. North. Am."},{"key":"1071_CR106","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","volume":"185","author":"S Ong","year":"2015","unstructured":"Ong, S. et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am. J. Pathol. 185, 847\u2013861 (2015).","journal-title":"Am. J. Pathol."},{"key":"1071_CR107","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.4049\/jimmunol.1301282","volume":"191","author":"JG Barin","year":"2013","unstructured":"Barin, J. G. et al. Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A. J. Immunol. 191, 4038\u20134047 (2013).","journal-title":"J. Immunol."},{"key":"1071_CR108","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.20161702","volume":"214","author":"NL Diny","year":"2017","unstructured":"Diny, N. L. et al. Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. J. Exp. Med. 214, 943\u2013957 (2017).","journal-title":"J. Exp. Med."},{"key":"1071_CR109","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrcardio.2009.229","volume":"7","author":"A Zanchetti","year":"2010","unstructured":"Zanchetti, A. Hypertension: cardiac hypertrophy as a target of antihypertensive therapy. Nat. Rev. Cardiol. 7, 66\u201367 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"1071_CR110","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.amjmed.2014.10.054","volume":"128","author":"F Rader","year":"2015","unstructured":"Rader, F., Sachdev, E., Arsanjani, R. & Siegel, R. J. Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications. Am. J. Med. 128, 344\u2013352 (2015).","journal-title":"Am. J. Med."},{"key":"1071_CR111","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1172\/JCI28884","volume":"116","author":"JC Tardiff","year":"2006","unstructured":"Tardiff, J. C. Cardiac hypertrophy: stressing out the heart. J. Clin. Invest. 116, 1467\u20131470 (2006).","journal-title":"J. Clin. Invest."},{"key":"1071_CR112","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I. & Minamino, T. Physiological and pathological cardiac hypertrophy. J. Mol. Cell Cardiol. 97, 245\u2013262 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1071_CR113","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/medicina58101455","volume":"58","author":"A Vural","year":"2022","unstructured":"Vural, A. & Aydin, E. The predictive value of eosinophil indices for major cardiovascular events in patients with acute decompensated HFrEF. Medicina 58, 1455 (2022).","journal-title":"Medicina"},{"key":"1071_CR114","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcla.22001","volume":"30","author":"N Silva","year":"2016","unstructured":"Silva, N., Patricio, E., Bettencourt, P. & Guimaraes, J. T. Evaluation of innate immunity biomarkers on admission and at discharge from an acute heart failure episode. J. Clin. Lab. Anal. 30, 1183\u20131190 (2016).","journal-title":"J. Clin. Lab. Anal."},{"key":"1071_CR115","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/00365513.2017.1325926","volume":"77","author":"M Dembic","year":"2017","unstructured":"Dembic, M., Hedley, P. L., Torp-Pedersen, C., Kober, L. & Christiansen, M. Pregnancy-associated plasma protein-A (PAPP-A) and the proform of the eosinophil major basic protein (ProMBP) are associated with increased risk of death in heart failure patients. Scand. J. Clin. Lab. Invest. 77, 352\u2013357 (2017).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"1071_CR116","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go, A. S. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285, 2370\u20132375 (2001).","journal-title":"JAMA"},{"key":"1071_CR117","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"Association European Heart Rhythm","year":"2006","unstructured":"European Heart Rhythm Association et al. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2014 executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48, 854\u2013906 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1071_CR118","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJM200104053441407","volume":"344","author":"RH Falk","year":"2001","unstructured":"Falk, R. H. Atrial fibrillation. N. Engl. J. Med. 344, 1067\u20131078 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1071_CR119","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(95)92339-X","volume":"346","author":"GY Lip","year":"1995","unstructured":"Lip, G. Y. Does atrial fibrillation confer a hypercoagulable state? Lancet 346, 1313\u20131314 (1995).","journal-title":"Lancet"},{"key":"1071_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136219","volume":"10","author":"JR Misialek","year":"2015","unstructured":"Misialek, J. R. et al. Association of white blood cell count and differential with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. PLoS ONE 10, e0136219 (2015).","journal-title":"PLoS ONE"},{"key":"1071_CR121","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/pace.13146","volume":"40","author":"P Chen","year":"2017","unstructured":"Chen, P., Chen, J., Xie, X., Zhu, J. & Xia, L. Eosinophils in patients with lone atrial fibrillation. Pacing Clin. Electrophysiol. 40, 955\u2013958 (2017).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"1071_CR122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/1076029613483208","volume":"20","author":"S Kecoglu","year":"2014","unstructured":"Kecoglu, S., Demir, M., Uyan, U. & Melek, M. The effects of eosinophil on the left atrial thrombus in patients with atrial fibrillation. Clin. Appl. Thromb. Hemost. 20, 285\u2013289 (2014).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"1071_CR123","doi-asserted-by":"publisher","first-page":"L110","DOI":"10.1093\/eurheartj\/suaa147","volume":"22","author":"I Cavallari","year":"2020","unstructured":"Cavallari, I. & Patti, G. Early risk of mortality, cardiovascular events, and bleeding in patients with newly diagnosed atrial fibrillation. Eur. Heart J. Suppl. 22, L110\u2013L113 (2020).","journal-title":"Eur. Heart J. Suppl."},{"key":"1071_CR124","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1160\/TH09-11-0771","volume":"104","author":"AP Owens III","year":"2010","unstructured":"Owens, A. P. III & Mackman, N. Tissue factor and thrombosis: the clot starts here. Thromb. Haemost. 104, 432\u2013439 (2010).","journal-title":"Thromb. Haemost."},{"key":"1071_CR125","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19812","volume":"4","author":"O Leiva","year":"2021","unstructured":"Leiva, O. et al. Association of thrombosis with hypereosinophilic syndrome in patients with genetic alterations. JAMA Netw. Open 4, e2119812 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1071_CR126","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11239-014-1151-9","volume":"40","author":"K Fujita","year":"2015","unstructured":"Fujita, K., Ishimaru, H., Hatta, K. & Kobashi, Y. Hypereosinophilic syndrome as a cause of fatal thrombosis: two case reports with histological study. J. Thromb. Thrombolysis 40, 255\u2013259 (2015).","journal-title":"J. Thromb. Thrombolysis"},{"key":"1071_CR127","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1016\/S0021-9258(19)67734-3","volume":"266","author":"A Slungaard","year":"1991","unstructured":"Slungaard, A. & Mahoney, J. R. Jr. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. J. Biol. Chem. 266, 4903\u20134910 (1991).","journal-title":"J. Biol. Chem."},{"key":"1071_CR128","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2005-05-2152","volume":"107","author":"JG Wang","year":"2006","unstructured":"Wang, J. G. et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 107, 558\u2013565 (2006).","journal-title":"Blood"},{"key":"1071_CR129","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1083\/jcb.101.2.363","volume":"101","author":"I Maruyama","year":"1985","unstructured":"Maruyama, I., Bell, C. E. & Majerus, P. W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J. Cell Biol. 101, 363\u2013371 (1985).","journal-title":"J. Cell Biol."},{"key":"1071_CR130","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood.V75.2.329.329","volume":"75","author":"WA Dittman","year":"1990","unstructured":"Dittman, W. A. & Majerus, P. W. Structure and function of thrombomodulin: a natural anticoagulant. Blood 75, 329\u2013336 (1990).","journal-title":"Blood"},{"key":"1071_CR131","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","volume":"264","author":"CT Esmon","year":"1989","unstructured":"Esmon, C. T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264, 4743\u20134746 (1989).","journal-title":"J. Biol. Chem."},{"key":"1071_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1055\/s-0038-1646155","volume":"70","author":"CT Esmon","year":"1993","unstructured":"Esmon, C. T. Molecular events that control the protein C anticoagulant pathway. Thromb. Haemost. 70, 29\u201335 (1993).","journal-title":"Thromb. Haemost."},{"key":"1071_CR133","first-page":"297","volume":"330","author":"S Takano","year":"1995","unstructured":"Takano, S. Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits. Arch. Int. Pharmacodyn. Ther. 330, 297\u2013308 (1995).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"1071_CR134","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1084\/jem.172.4.1271","volume":"172","author":"MS Rohrbach","year":"1990","unstructured":"Rohrbach, M. S., Wheatley, C. L., Slifman, N. R. & Gleich, G. J. Activation of platelets by eosinophil granule proteins. J. Exp. Med. 172, 1271\u20131274 (1990).","journal-title":"J. Exp. Med."},{"key":"1071_CR135","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0038-1657363","volume":"49","author":"DI Cargill","year":"1983","unstructured":"Cargill, D. I., Cohen, D. S., Van Valen, R. G., Klimek, J. J. & Levin, R. P. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). Thromb. Haemost. 49, 204\u2013207 (1983).","journal-title":"Thromb. Haemost."},{"key":"1071_CR136","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmed.2017.00129","volume":"4","author":"SA Shah","year":"2017","unstructured":"Shah, S. A., Page, C. P. & Pitchford, S. C. Platelet\u2013eosinophil interactions as a potential therapeutic target in allergic inflammation and asthma. Front. Med. 4, 129 (2017).","journal-title":"Front. Med."},{"key":"1071_CR137","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1536\/ihj.50.267","volume":"50","author":"T Sakai","year":"2009","unstructured":"Sakai, T. et al. Eosinophils may be involved in thrombus growth in acute coronary syndrome. Int. Heart J. 50, 267\u2013277 (2009).","journal-title":"Int. Heart J."},{"key":"1071_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113870","volume":"9","author":"K Yamaji","year":"2014","unstructured":"Yamaji, K. et al. Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis. PLoS ONE 9, e113870 (2014).","journal-title":"PLoS ONE"},{"key":"1071_CR139","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehv419","volume":"37","author":"J Riegger","year":"2016","unstructured":"Riegger, J. et al. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium. Eur. Heart J. 37, 1538\u20131549 (2016).","journal-title":"Eur. Heart J."},{"key":"1071_CR140","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jvsv.2020.10.012","volume":"9","author":"AK Mansiroglu","year":"2021","unstructured":"Mansiroglu, A. K., Sincer, I., Cosgun, M. & Gunes, Y. Dating thrombus organization with eosinophil counts in deep venous thrombosis. J. Vasc. Surg. Venous Lymphat. Disord. 9, 874\u2013880 (2021).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"1071_CR141","doi-asserted-by":"publisher","first-page":"717","DOI":"10.5152\/AnatolJCardiol.2022.1780","volume":"26","author":"S Kulahcioglu","year":"2022","unstructured":"Kulahcioglu, S. et al. Eosinophil-to-monocyte ratio as a candidate for a novel prognostic marker in acute pulmonary embolism: is it a consumptive mechanism? Anatol. J. Cardiol. 26, 717\u2013724 (2022).","journal-title":"Anatol. J. Cardiol."},{"key":"1071_CR142","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1474-4422(18)30336-3","volume":"17","author":"JF Scheitz","year":"2018","unstructured":"Scheitz, J. F., Nolte, C. H., Doehner, W., Hachinski, V. & Endres, M. Stroke\u2013heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol. 17, 1109\u20131120 (2018).","journal-title":"Lancet Neurol."},{"key":"1071_CR143","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrn1106","volume":"4","author":"EH Lo","year":"2003","unstructured":"Lo, E. H., Dalkara, T. & Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399\u2013415 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"1071_CR144","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","volume":"39","author":"J Palasubramaniam","year":"2019","unstructured":"Palasubramaniam, J., Wang, X. & Peter, K. Myocardial infarction \u2014 from atherosclerosis to thrombosis. Arterioscler. Thromb. Vasc. Biol. 39, e176\u2013e185 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1071_CR145","first-page":"774","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch, G. & Gersh, B. J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur. Heart J. 38, 774\u2013784 (2017).","journal-title":"Eur. Heart J."},{"key":"1071_CR146","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.007","volume":"25","author":"YS Hori","year":"2016","unstructured":"Hori, Y. S., Kodera, S., Sato, Y. & Shiojiri, T. Eosinopenia as a predictive factor of the short-term risk of mortality and infection after acute cerebral infarction. J. Stroke Cerebrovasc. Dis. 25, 1307\u20131312 (2016).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1071_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1359-6","volume":"19","author":"N Juceviciute","year":"2019","unstructured":"Juceviciute, N., Mikuzis, P. & Balnyte, R. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke. BMC Neurol. 19, 127 (2019).","journal-title":"BMC Neurol."},{"key":"1071_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-021-00610-x","volume":"22","author":"S Yu","year":"2021","unstructured":"Yu, S. et al. Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke. BMC Neurosci. 22, 8 (2021).","journal-title":"BMC Neurosci."},{"key":"1071_CR149","doi-asserted-by":"publisher","first-page":"709289","DOI":"10.3389\/fimmu.2021.709289","volume":"12","author":"D Yang","year":"2021","unstructured":"Yang, D. et al. Dynamic decrease in eosinophil after intravenous thrombolysis predicts poor prognosis of acute ischemic stroke: a longitudinal study. Front. Immunol. 12, 709289 (2021).","journal-title":"Front. Immunol."},{"key":"1071_CR150","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/CIA.S309923","volume":"16","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Eosinophil-to-monocyte ratio is a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. Clin. Interv. Aging 16, 853\u2013862 (2021).","journal-title":"Clin. Interv. Aging"},{"key":"1071_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22244","volume":"32","author":"L Fan","year":"2018","unstructured":"Fan, L., Gui, L., Chai, E. Q. & Wei, C. J. Routine hematological parameters are associated with short- and long-term prognosis of patients with ischemic stroke. J. Clin. Lab. Anal. 32, e22244 (2018).","journal-title":"J. Clin. Lab. Anal."},{"key":"1071_CR152","doi-asserted-by":"publisher","first-page":"104999","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104999","volume":"29","author":"M Gunes","year":"2020","unstructured":"Gunes, M. Is neutrophil\/eosinophil ratio at admission a prognostic marker for in-hospital mortality of acute ischemic stroke? J. Stroke Cerebrovasc. Dis. 29, 104999 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1071_CR153","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1161\/STROKEAHA.117.018450","volume":"48","author":"J Sundstrom","year":"2017","unstructured":"Sundstrom, J. et al. Eosinophil cationic protein, carotid plaque, and incidence of stroke. Stroke 48, 2686\u20132692 (2017).","journal-title":"Stroke"},{"key":"1071_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58368-x","volume":"10","author":"SW Watts","year":"2020","unstructured":"Watts, S. W., Flood, E. D., Garver, H., Fink, G. D. & Roccabianca, S. A new function for perivascular adipose tissue (PVAT): assistance of arterial stress relaxation. Sci. Rep. 10, 1807 (2020).","journal-title":"Sci. Rep."},{"key":"1071_CR155","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","volume":"138","author":"G Ailawadi","year":"2009","unstructured":"Ailawadi, G. et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg. 138, 1392\u20131399 (2009).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1071_CR156","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","volume":"35","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist, E. et al. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 960\u2013972 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1071_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/srep44571","volume":"7","author":"SB Withers","year":"2017","unstructured":"Withers, S. B. et al. Eosinophils are key regulators of perivascular adipose tissue and vascular functionality. Sci. Rep. 7, 44571 (2017).","journal-title":"Sci. Rep."},{"key":"1071_CR158","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/joim.13040","volume":"288","author":"M Langenskiold","year":"2020","unstructured":"Langenskiold, M., Smidfelt, K., Nordanstig, J., Bergstrom, G. & Tivesten, A. Leukocyte subsets and abdominal aortic aneurysms detected by screening in men. J. Intern. Med. 288, 345\u2013355 (2020).","journal-title":"J. Intern. Med."},{"key":"1071_CR159","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/acs.2016.05.04","volume":"5","author":"C Harris","year":"2016","unstructured":"Harris, C., Croce, B. & Cao, C. Type A aortic dissection. Ann. Cardiothorac. Surg. 5, 256 (2016).","journal-title":"Ann. Cardiothorac. Surg."},{"key":"1071_CR160","first-page":"339","volume":"3","author":"CG Harris","year":"2014","unstructured":"Harris, C. G., Croce, B. & Tian, D. H. Type B aortic dissection. Ann. Cardiothorac. Surg. 3, 339 (2014).","journal-title":"Ann. Cardiothorac. Surg."},{"key":"1071_CR161","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12872-022-02592-y","volume":"22","author":"Y Shao","year":"2022","unstructured":"Shao, Y. et al. Impacts of eosinophil percentage on prognosis acute type A aortic dissection patients. BMC Cardiovasc. Disord. 22, 146 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1071_CR162","doi-asserted-by":"publisher","first-page":"969995","DOI":"10.3389\/fsurg.2022.969995","volume":"9","author":"X Qin","year":"2022","unstructured":"Qin, X. et al. The role of peripheral blood eosinophil counts in acute Stanford type A aortic dissection patients. Front. Surg. 9, 969995 (2022).","journal-title":"Front. Surg."},{"key":"1071_CR163","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027339","volume":"11","author":"K Zhao","year":"2022","unstructured":"Zhao, K. et al. Peripheral eosinophil count is associated with the prognosis of patients with type B aortic dissection undergoing endovascular aortic repair: a retrospective cohort study. J. Am. Heart Assoc. 11, e027339 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"1071_CR164","doi-asserted-by":"publisher","first-page":"687192","DOI":"10.3389\/fimmu.2021.687192","volume":"12","author":"J Miyata","year":"2021","unstructured":"Miyata, J. et al. 12\/15-Lipoxygenase regulates IL-33-induced eosinophilic airway inflammation in mice. Front. Immunol. 12, 687192 (2021).","journal-title":"Front. Immunol."},{"key":"1071_CR165","doi-asserted-by":"publisher","first-page":"106477","DOI":"10.1016\/j.prostaglandins.2020.106477","volume":"150","author":"J Miyata","year":"2020","unstructured":"Miyata, J. et al. Dysregulated metabolism of polyunsaturated fatty acids in eosinophilic allergic diseases. Prostaglandins Other Lipid Mediat. 150, 106477 (2020).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"1071_CR166","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.ajpath.2011.07.039","volume":"179","author":"JC Masterson","year":"2011","unstructured":"Masterson, J. C. et al. CCR3 blockade attenuates eosinophilic ileitis and associated remodeling. Am. J. Pathol. 179, 2302\u20132314 (2011).","journal-title":"Am. J. Pathol."},{"key":"1071_CR167","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jaci.2012.07.048","volume":"131","author":"J Miyata","year":"2013","unstructured":"Miyata, J. et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J. Allergy Clin. Immunol. 131, 353\u2013360 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1071_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-016-0094-3","volume":"9","author":"DD Metcalfe","year":"2016","unstructured":"Metcalfe, D. D. et al. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ. J. 9, 7 (2016).","journal-title":"World Allergy Organ. J."},{"key":"1071_CR169","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cea.12292","volume":"44","author":"MW Johansson","year":"2014","unstructured":"Johansson, M. W. Activation states of blood eosinophils in asthma. Clin. Exp. Allergy 44, 482\u2013498 (2014).","journal-title":"Clin. Exp. Allergy"},{"key":"1071_CR170","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.201109-1712OC","volume":"185","author":"MW Johansson","year":"2012","unstructured":"Johansson, M. W. et al. Platelet activation, P-selectin, and eosinophil beta1-integrin activation in asthma. Am. J. Respir. Crit. Care Med. 185, 498\u2013507 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1071_CR171","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.4049\/jimmunol.1601005","volume":"198","author":"C Lingblom","year":"2017","unstructured":"Lingblom, C., Andersson, J., Andersson, K. & Wenneras, C. Regulatory eosinophils suppress T cells partly through galectin-10. J. Immunol. 198, 4672\u20134681 (2017).","journal-title":"J. Immunol."},{"key":"1071_CR172","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood.V58.6.1175.1175","volume":"58","author":"SH Pincus","year":"1981","unstructured":"Pincus, S. H., Schooley, W. R., DiNapoli, A. M. & Broder, S. Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood 58, 1175\u20131181 (1981).","journal-title":"Blood"},{"key":"1071_CR173","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.redox.2012.11.001","volume":"1","author":"W Li","year":"2013","unstructured":"Li, W., McIntyre, T. M. & Silverstein, R. L. Ferric chloride-induced murine carotid arterial injury: a model of redox pathology. Redox Biol. 1, 50\u201355 (2013).","journal-title":"Redox Biol."},{"key":"1071_CR174","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.20161070","volume":"214","author":"S Uderhardt","year":"2017","unstructured":"Uderhardt, S. et al. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J. Exp. Med. 214, 2121\u20132138 (2017).","journal-title":"J. Exp. Med."},{"key":"1071_CR175","first-page":"772","volume":"81","author":"DH Blankenhorn","year":"1959","unstructured":"Blankenhorn, D. H. & Stern, D. Calcification of the coronary arteries. Am. J. Roentgenol. Radium Ther. Nucl. Med. 81, 772\u2013777 (1959).","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"1071_CR176","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCRESAHA.115.307523","volume":"117","author":"P Libby","year":"2015","unstructured":"Libby, P. Murine \u2018model\u2019 monotheism: an iconoclast at the altar of mouse. Circ. Res. 117, 921\u2013925 (2015).","journal-title":"Circ. Res."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01071-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:03:30Z","timestamp":1739865810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01071-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":176,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1038\/s41569-024-01071-5","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"7 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}